Healthcare


Ipsos Update Publication

Ipsos Update – April 2025

Canada, Italy, Women's Day … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
Mental Health Survey

AXA Mind Health Report : Mental health continues to deteriorate around the world

Mental health around the world continues to deteriorate according to the fifth edition of the AXA Mental Health Report. The study, conducted in collaboration with Ipsos, aims to identify mental health and well-being issues around the world in order to develop solutions to alleviate them. Ipsos surveyed 17,000 people from 16 countries across Europe, the United States and Asia.
Healthcare Publication

Podcast: Early Diagnosis of Alzheimer’s: Understanding the Bigger Picture

Listen to the third episode of Ipsos’ podcast series, “Healthcare Uncovered" with Hannah Brown and Ayse Levent
Healthcare Survey

European Observatory of Rare Diseases reveals that Europeans find conditions for patients with rare diseases are unacceptable

ASAP FOR CHILDREN has published the results of its third European Rare Disease Observatory conducted by Ipsos.
Healthcare Publication

Ipsos Update - November 2024

Mental Health, AI, Infrastructure … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
Healthcare Publication

GLP–1s: A Healthcare Revolution?

One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.
Mental Health Survey

Ipsos World Mental Health Day Report

Younger people (particularly young women) are the most likely to feel depressed and take time off work due to stress according to an Ipsos report for World Mental Health Day 2024
Ipsos Update Publication

Ipsos Update - October 2024

Trends, News, Ageing … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
Public Health Publication

Predicting Opportunity in Emerging Therapies

The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.